Study to determine the local prevalence in Indian patients in Prostate cancer
Not Applicable
Completed
- Conditions
- Health Condition 1: C61- Malignant neoplasm of prostate
- Registration Number
- CTRI/2021/12/038578
- Lead Sponsor
- AstraZeneca Pharma India Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 211
Inclusion Criteria
1.Male participants aged =18 = 80 years of age.
2. Pathological mCRPC cases confirmed by laboratory (PSA and testosterone levels), X-rays (optional),(CT scan/ MRI scan / PET scan) .
3. Availability of medical history (demographic information and history of cancer)
4. Participants who are able to provide written informed consent form (ICF).
Exclusion Criteria
1. Diagnosis of any severe acute or chronic medical or psychiatric conditions that may increase the risk associated with study participation or may interfere with the interpretation of the study results.
2. Newly diagnosed mCRPC participants without tissue sample availability.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method